Publicaciones en colaboración con investigadores/as de University of Manchester (19)

2019

  1. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

2017

  1. An MIF promoter polymorphism is associated with susceptibility to pulmonary arterial hypertension in diffuse cutaneous systemic sclerosis

    Journal of Rheumatology, Vol. 44, Núm. 10, pp. 1453-1457

  2. Analysis of ATP8B4 F436L Missense Variant in a Large Systemic Sclerosis Cohort

    Arthritis and Rheumatology, Vol. 69, Núm. 6, pp. 1337-1338

2016

  1. Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 8, pp. 1521-1526

2015

  1. A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility

    American Journal of Human Genetics, Vol. 96, Núm. 4, pp. 565-580

2014

  1. A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility

    Arthritis Research and Therapy, Vol. 16, Núm. 1

  2. Identification of IL12RB1 as a Novel Systemic Sclerosis Susceptibility Locus

    Arthritis and Rheumatology

  3. Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis

    American Journal of Human Genetics, Vol. 94, Núm. 1, pp. 47-61

2013

  1. Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 4, pp. 602-607

  2. The Systemic Lupus Erythematosus IRF5 Risk Haplotype Is Associated with Systemic Sclerosis

    PLoS ONE, Vol. 8, Núm. 1

2012

  1. A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations

    Human Molecular Genetics, Vol. 21, Núm. 4, pp. 926-933

  2. A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis

    Arthritis Research and Therapy, Vol. 14, Núm. 2

  3. A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators

    Arthritis and Rheumatism, Vol. 64, Núm. 1, pp. 264-271

  4. KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factor

    Arthritis Research and Therapy, Vol. 14, Núm. 6

  5. Polymorphisms in the interleukin 4, interleukin 13, and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expression

    Journal of Rheumatology, Vol. 39, Núm. 1, pp. 112-118

  6. The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis

    Genes and Immunity, Vol. 13, Núm. 2, pp. 191-196

2011

  1. A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort

    Annals of the Rheumatic Diseases, Vol. 70, Núm. 4, pp. 638-641

  2. Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis

    Annals of the Rheumatic Diseases

2010

  1. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

    Nature Genetics, Vol. 42, Núm. 5, pp. 426-429